Home › Funds › Willis Investment Counsel › DGX
Willis Investment Counsel position in DGX
QUEST DIAGNOSTICS INC · Health Care
Willis Investment Counsel reported holding 117,200 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$27.3M, representing 1.39% of its reported portfolio and ranking #24 among its reported holdings. Willis Investment Counsel has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Willis Investment Counsel's DGX position evolved
Willis Investment Counsel first disclosed a stake in DGX in Q3 2023 at 136,800 shares (US$16.7M). The position peaked in Q2 2026 at 151,500 shares, worth US$32.1M. Across 13 filings, Willis Investment Counsel increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 117,200 shares valued at US$27.3M — a reduction of -34,300 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 136.80K | $16.67M | New |
| Q4 2023 | 136.30K | $18.79M | Hold |
| Q1 2024 | 136.30K | $18.14M | Hold |
| Q2 2024 | 136.30K | $18.66M | Hold |
| Q3 2024 | 120.10K | $18.65M | Reduce |
| Q4 2024 | 120.10K | $18.12M | Hold |
| Q1 2025 | 120.10K | $20.32M | Hold |
| Q2 2025 | 136.90K | $24.59M | Add |
| Q3 2025 | 151.80K | $28.93M | Add |
| Q4 2025 | 151.80K | $26.34M | Hold |
| Q1 2026 | 151.80K | $29.75M | Hold |
| Q2 2026 | 151.50K | $32.11M | Hold |
| Q3 2026 | 117.20K | $27.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 26 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.64M sh · $1.08B · Q3 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.93M sh · $449.89M · Q3 2026
- DAVIS SELECTED ADVISERS 1.33M sh · $308.97M · Q3 2026
- M&G Plc 770.10K sh · $179.43M · Q3 2026
More on Willis Investment Counsel
FAQ
How long has Willis Investment Counsel held DGX?
Willis Investment Counsel has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Willis Investment Counsel's current position in DGX?
As of Q3 2026, Willis Investment Counsel holds 117.20K shares of DGX (QUEST DIAGNOSTICS INC), valued at $27.32M, representing 1.39% of its reported portfolio and ranking #24.
Has Willis Investment Counsel been buying or selling DGX?
In the latest 13F filing (Q3 2026), Willis Investment Counsel reduced its position in DGX. The position peaked in Q2 2026 at 151.50K shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.